Amnovis and BAAT Medical collaborate on innovation in the development and production of 3D printed medical devices
Flam3D member Amnovis and BAAT Medical have partnered to jointly offer an innovative and rapid turnaround process for 3D printed medical devices. Both complementary companies jointly span the entire process, from the initial design idea through medical engineering to legally produced devices ready for use.
The business focus and technology expertise shared by Amnovis and BAAT Medical lead to more innovative business models and better 3D printed medical devices. Their joint technology roadmap, focused on the development of new medical device applications and the validation of state-of-the-art AM technologies and related processes, is driving medical device innovation. This allows medical device start-ups and OEMs to benefit from a faster time-to-market for 3D printed medical devices that excel in patient outcomes.
“Together, we want to build on the complementary expertise of Amnovis and BAAT Medical to collaborate and take 3D printing of medical devices to the next level.”
Gert Nijenbanning, Managing Director of BAAT Medical
Over the past few decades, Additive Manufacturing (AM) has earned a reputation for innovation in the medical industry. BAAT Medical has pioneered the engineering and development of 3D printed spinal fusion implants, resulting in multiple CE marks and FDA approvals and over 50,000 implants manufactured to date. The founders of Amnovis have a proven track record, dating back to 2008, in using AM to create high-end products. They were among the first to use L-PFB to print medical devices from titanium, such as orthopaedic and spinal implants.
“We are extremely proud of the cooperation with BAAT Medical. We see great potential in jointly innovating various AM medical device applications.”
Ruben Wauthle, CEO and co-founder of Amnovis
The collaboration between Amnovis and BAAT Medical combines the best of both companies. Together they have a more comprehensive view on how to optimally align design and development as well as material selection and manufacturing in the context of specific AM applications for medical devices. Both companies work on a joint technology and application roadmap and actively validate new AM technologies to set new standards for specific types of medical devices. They are aligning these efforts with the business potential and time-to-market of new AM technologies in the medical sector. As part of these efforts, they are taking a closer look at AM materials and post-processing methods, as well as process automation and validation.
Ruben Wauthle, CEO and co-founder of Flam3D member Amnovis: “We are extremely proud of the collaboration with BAAT Medical. We see great potential in jointly innovating various AM medical device applications. We have known each other for years, share the same innovative drive, and work closely together to better align design and development with material selection and manufacturing. As preferred partners, we offer our customers and prospects a complete process for aiming high and acting fast, while clearing the hurdles in medical device development, validation and manufacturing. At Amnovis, we rely on our comprehensive AM workflow and manufacturing platform, which is fully ISO 13485:2016 certified. Digital process automation allows us to provide full traceability and repeatability to flexibly scale up production of standard and patient-specific AM medical devices.”
Gert Nijenbanning, Managing Director of BAAT Medical: “It is great to intensify our collaboration with the AM innovators at Amnovis, with whom we have already worked successfully in the past. We believe that efficiency in development and production throughout the chain is essential to keep investment in medical device innovations viable, especially for European markets where MDR is a reality. Together, we aim to build on the complementary expertise of Amnovis and BAAT Medical to collaborate and take 3D printing of medical devices to the next level.”
